Medicure’s 100-Bagger Returns in 2013-2016

NIA’s #1 pick to become a 100-bagger in the years ahead, Medicure (TSXV: MPH), already became a 100-bagger once before. Between June 2013 and December 2016, Medicure (TSXV: MPH) rose from $0.10 per share up to $10.67 per share for a gain of 10,570% in 42 months. From the lows reached in recent years, Medicure (TSXV: MPH) will become a 100-bagger once again.

If you are too lazy to do research, you can ask Claude if their MC-1 drug is likely to work for PNPO deficiency and get FDA approval.

Medicure (TSXV: MPH) will be trading for $30 per share by this time next year.

Past performance is not indicative of future results. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. NIA’s President has purchased 87,000 shares of MPH and intends to buy more shares.This communication is for informational and educational purposes only.